Chemical context   {#sec1}
==================

An important property of di­amino­pyrimidine derivatives is their inhibition potential against cancer targets. Because of the limited capacity of drugs that can cure cancer, there is always an urgent requirement for new chemotherapeutics. 2,4-Di­amino­pyrimidine derivatives combined with aryl­thia­zole derivatives have shown to possess significant anti-proliferation properties against breast cancer cell lines (Zhou *et al.*, 2015[@bb19]). 2,4-Di­amino­pyrimidine derivatives have shown significant inhibitory activity against influenza viruses (Kimura *et al.*, 2006[@bb7]). A series of 2,4- di­amino­pyrimidine derivatives were evaluated against Bacillus anthracis, which showed inhibition (Nammalwar *et al.*, 2012[@bb10]). Di­hydro­folate reductase inhibitor drugs such as pyrimethamine, trimetrexate and piritrexim (Nelson & Rosowsky, 2001[@bb11]) and the anti­biotics iclaprim and trimethoprim all include di­amino­pyrimidine as the fundamental structural motif. Di­amino­pyrimidine derivatives have also shown anti-retroviral activity (Hocková *et al.*, 2004[@bb4]), anti­bacterial (Kandeel *et al.*, 1994[@bb6]) and potential anti-microbial properties (Holla *et al.*, 2006[@bb5]). As part of our own studies in this area, we report herein on the syntheses, crystal structures and Hirshfeld surface analyses of the title compounds, 2-\[(4,6-di­amino­pyrimidin-2-yl)sulfan­yl\]-*N*-(pyridin-2-yl)acet­amide (I)[](#scheme1){ref-type="chem"} and 2-\[(4,6-di­amino­pyrimidin-2-yl)sulfan­yl\]-*N*-(pyrazin-2-yl)acetamide (II)[](#scheme1){ref-type="chem"}.

Structural commentary   {#sec2}
=======================

The mol­ecular structure of compounds (I)[](#scheme1){ref-type="chem"} and (II)[](#scheme1){ref-type="chem"} are shown in the Figs. 1[▸](#fig1){ref-type="fig"} and 2[▸](#fig2){ref-type="fig"}, respectively. Compound (I)[](#scheme1){ref-type="chem"} crystallizes in the triclinic space group *P* and compound (II)[](#scheme1){ref-type="chem"} crystallizes in the monoclinic space group *P*2~1~/*c*. In both the compounds, there is an intra­molecular N---H⋯N hydrogen bond forming an *S*(7) ring motif and a short C---H⋯O inter­action forming an *S*(6) loop; see Tables 1[▸](#table1){ref-type="table"} and 2[▸](#table2){ref-type="table"} for details of the hydrogen bonding. The nitro­gen atoms N1 and N2 lie in the plane of the pyrimidine ring to which they are attached \[deviations are −0.0269 (17) and 0.0521 (16) Å, respectively, for compound (I)[](#scheme1){ref-type="chem"}, and 0.0350 (28) and 0.0284 (28) Å, respectively, for compound (II)\]. The di­amino­pyrimidine ring makes a dihedral angle of 71.10 (9)° with the pyridine ring in compound (I)[](#scheme1){ref-type="chem"} and a dihedral angle of 62.93 (15)° with the pyrazine ring in compound (II)[](#scheme1){ref-type="chem"}. In (I)[](#scheme1){ref-type="chem"} the ethanamine group (N5/O1/C6/C5) and the pyridine ring are coplanar, as evidenced by torsion angle C7---N5---C6---C5 = 179.1 (2)°. In (II)[](#scheme1){ref-type="chem"} the ethanamine group (N5/O1/C6/C5) and pyrazine ring also lie in a plane \[C7---N5---C6---C5 = 177.6 (3)°\]. Bond lengths C4---S1 \[1.768 (2) Å\] and C5---S1 \[1.802 (2) Å\] for compound (I)[](#scheme1){ref-type="chem"}, and C4---S1 \[1.768 (3) Å\] and C5---S1 \[1.795 (3) Å\] for compound (II)[](#scheme1){ref-type="chem"}, are comparable with values reported for similar compounds (see Section 4. *Database survey*).

Supra­molecular features   {#sec3}
==========================

The crystal packing in compound (I)[](#scheme1){ref-type="chem"} is illustrated in Fig. 3[▸](#fig3){ref-type="fig"}, and that for compound (II)[](#scheme1){ref-type="chem"} in Fig. 4[▸](#fig4){ref-type="fig"}. Details of the hydrogen-bonding geometry in compound (I)[](#scheme1){ref-type="chem"} are given in Table 1[▸](#table1){ref-type="table"} and in Table 2[▸](#table2){ref-type="table"} for (II)[](#scheme1){ref-type="chem"}. In the crystals of both compounds, mol­ecules are linked by pairs of N2---H2*B*⋯N4^i^ hydrogen bonds, forming inversion dimers with (8) ring motifs (Figs. 3[▸](#fig3){ref-type="fig"} and 4[▸](#fig4){ref-type="fig"}, respectively).

In the crystal of (I)[](#scheme1){ref-type="chem"}, the dimers are linked by N2---H2*A*⋯O1^iii^ hydrogen bonds, forming ribbons along \[010\], enclosing (18) ring motifs. Adjacent ribbons are linked by N1---H1*A*⋯N6^ii^ hydrogen bonds, forming sheets lying parallel to the (1 ) plane, see Fig. 3[▸](#fig3){ref-type="fig"}. The layers are linked by offset π--π inter­actions, forming a three-dimensional supra­molecular structure \[*Cg*⋯*Cg* ^v^ = 3.777 (1) Å, inter­planar distance = 3.483 (1) Å, slippage = 1.459 Å, *Cg* is the centroid of the pyridine ring (N6/C7--C11); symmetry code: (v) −*x* + 1, −*y*, −*z* + 1)\].

In the crystal of (II)[](#scheme1){ref-type="chem"}, the dimers are linked by N1---H1*A*⋯O^ii^, N2---H2*A*⋯N7^iii^ and C9---H9⋯O1^iv^ hydrogen bonds (Table 2[▸](#table2){ref-type="table"}), forming a three-dimensional supra­molecular structure (Fig. 4[▸](#fig4){ref-type="fig"}). In contrast, in the crystal of (II)[](#scheme1){ref-type="chem"} there are no π--π inter­actions present.

Database survey   {#sec4}
=================

A search of the Cambridge Structure Database (Version 5.39, last update February 2018; Groom *et al.*, 2016[@bb3]) for \[(4,6-di­amino­pyrmidin-2-yl)sulfan­yl\]acetamide yielded nine hits, eight of which have a substituted phenyl substituent in place of the pyridine ring in (I)[](#scheme1){ref-type="chem"} and the pyrazine ring in (II)[](#scheme1){ref-type="chem"}, and one a naphthalene group (JARPOK; Subasri *et al.*, 2017*a* [@bb16]). They include the following analogues: 3-nitro­phenyl (ARAROC; Subasri *et al.*, 2016[@bb18]), 2-chloro­phenyl (ARARUI; Subasri *et al.*, 2016[@bb18]), 2-methyl­phenyl (GOKWIO; Subasri *et al.*, 2014[@bb15]), 4-fluoro­phenyl (JARPUQ; Subasri *et al.*, 2017*a* [@bb16]), 2,4-di­methyl­phenyl (JAXFIA; Choudhury *et al.*, 2017[@bb2]), 3-meth­oxy­phenyl (JAXFOG; Choudhury *et al.*, 2017[@bb2]), 4-chloro­phenyl (KAPQIE; Subasri *et al.*, 2017*b* [@bb17]), and 3-chloro­phenyl (KAPQOK; Subasri *et al.*, 2017*b* [@bb17]).

In these eight compounds, the di­amino­pyrimidine and benzene rings are inclined to one another by dihedral angles varying from *ca* 42.25 to 78.33°. The dihedral angle between the di­amino­pyrimidine and the pyridine ring in (I)[](#scheme1){ref-type="chem"} is 71.10 (9)° and with the pyrazine ring in (II)[](#scheme1){ref-type="chem"} is 62.93 (15)°, well within these limits. As in the title compounds, there is also an intra­molecular N---H⋯N hydrogen bond present in all eight compounds, stabilizing the folded conformation of each mol­ecule. In the crystals of all but two compounds (ARAROC and JARPUQ), mol­ecules are linked by pairs of N---H⋯N hydrogen bonds, involving the 4,6-di­amino­pyrimidine moieties, forming inversion dimers with (8) ring motifs, as for compounds (I)[](#scheme1){ref-type="chem"} and (II)[](#scheme1){ref-type="chem"}.

Hirshfeld surface analysis   {#sec5}
============================

In Figs. 5[▸](#fig5){ref-type="fig"} and 6[▸](#fig6){ref-type="fig"}, the ball and stick model of the front and back views of the compounds (I)[](#scheme1){ref-type="chem"} and (II)[](#scheme1){ref-type="chem"}, respectively, and the inter­molecular contacts are shown by conventional mapping of *d* ~norm~ on the mol­ecular Hirshfeld surfaces, where the red-spot areas denote inter­molecular contacts involved in the hydrogen-bonding inter­actions (McKinnon *et al.*, 2007[@bb9]). The electrostatic potential is mapped on the Hirshfeld surface using the STO-3G basis set at the Hartree--Fock theory over the range of ±0.025 a.u. The positive electrostatic potential (blue region) over the surface shows hydrogen-donor potential, and the hydrogen-bond acceptors are shown by negative electrostatic potential (red regions); see Figs. 5[▸](#fig5){ref-type="fig"} and 6[▸](#fig6){ref-type="fig"}. The two-dimensional fingerprint plots \[Fig. 7[▸](#fig7){ref-type="fig"} for (I)[](#scheme1){ref-type="chem"} and Fig. 8[▸](#fig8){ref-type="fig"} for (II)\] are deconvoluted to highlight atom-pair close contacts by which different atomic types, overlapping the full fingerprint can be separated based on different inter­action types. For compound (I)[](#scheme1){ref-type="chem"}, inter­molecular H⋯H contacts of 39.1% are the most significant, followed by 17.7% for N⋯H/H⋯N, 12% for C⋯H/H⋯C, 9.3% for O⋯H/H⋯O, 8.4% for S⋯H/H⋯S and 4.1% for C⋯C contacts. In contrast, for compound (II)[](#scheme1){ref-type="chem"} the H⋯H contacts at 28.2% are significantly lower than in (I)[](#scheme1){ref-type="chem"}, while the N⋯H/H⋯N contacts at 27% are significantly higher than in (I)[](#scheme1){ref-type="chem"}. The C⋯C contacts at only 1.9% are much lower than in (I)[](#scheme1){ref-type="chem"} where offset π--π inter­actions are observed in the crystal structure.

Synthesis and crystallization   {#sec6}
===============================

**Compound (I)[](#scheme1){ref-type="chem"}:** To a solution of 4, 6-di­amino-pyrimidine-2-thiol (0.5 g; 3.52 mmol) in 25 ml of ethanol, (0.2g; 3.52 mmol) potassium hydroxide was added and refluxed for about 30 min. Then an equimolar qu­antity of 2-chloro-*N*-(pyridin-2-yl)acetamide (3.52 mmol) was added to the above reaction mixture and it was refluxed for 5 h. Evaporation of the organic layer under vacuum provided compound (I)[](#scheme1){ref-type="chem"}. After purification, the compound was crystallized from ethanol solution by slow evaporation of the solvent giving yellow block-like crystals.

**Compound (II)**: To a solution of 4, 6-di­amino-pyrimidine-2-thiol (0.5 g; 3.52 mmol) in 25 ml of ethanol, (0.2g; 3.52 mmol) potassium hydroxide was added and refluxed for about 30 min. Then an equimolar qu­antity of 2-chloro-*N*-(pyrazin-2-yl)acetamide (3.52 mmol) was added to the above reaction mixture and it was refluxed for 5.5 h. Evaporation of the organic layer under vacuum resulted in compound (II)[](#scheme1){ref-type="chem"}. After purification, the compound was crystallized from ethanol solution by slow evaporation of the solvent giving yellow block-like crystals.

Refinement   {#sec7}
============

Crystal data, data collection and structure refinement details are summarized in Table 3[▸](#table3){ref-type="table"}. For both compounds, the NH~2~ and NH H atoms were located in difference-Fourier maps and freely refined, and the C-bound H atoms were placed in calculated positions and refined in the riding model: C---H = 0.93--0.97 Å with *U* ~iso~(H) = 1.2*U* ~eq~(C).

Supplementary Material
======================

Crystal structure: contains datablock(s) global, I, II. DOI: [10.1107/S2056989018005704/su5430sup1.cif](https://doi.org/10.1107/S2056989018005704/su5430sup1.cif)

Structure factors: contains datablock(s) I. DOI: [10.1107/S2056989018005704/su5430Isup4.hkl](https://doi.org/10.1107/S2056989018005704/su5430Isup4.hkl)

Structure factors: contains datablock(s) II. DOI: [10.1107/S2056989018005704/su5430IIsup5.hkl](https://doi.org/10.1107/S2056989018005704/su5430IIsup5.hkl)

###### 

Click here for additional data file.

Supporting information file. DOI: [10.1107/S2056989018005704/su5430Isup4.cml](https://doi.org/10.1107/S2056989018005704/su5430Isup4.cml)

###### 

Click here for additional data file.

Supporting information file. DOI: [10.1107/S2056989018005704/su5430IIsup5.cml](https://doi.org/10.1107/S2056989018005704/su5430IIsup5.cml)

CCDC references: [1836419](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1836419), [1836418](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1836418)

Additional supporting information: [crystallographic information](http://scripts.iucr.org/cgi-bin/sendsupfiles?su5430&file=su5430sup0.html&mime=text/html); [3D view](http://scripts.iucr.org/cgi-bin/sendcif?su5430sup1&Qmime=cif); [checkCIF report](http://scripts.iucr.org/cgi-bin/paper?su5430&checkcif=yes)

The authors thank the TBI X-ray facility, CAS in Crystallography and Biophysics, University of Madras, India, for the data collection

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Crystal data {#d1e151}
=======================================================================================

  ----------------------- ---------------------------------------
  C~11~H~12~N~6~OS        *Z* = 2
  *M~r~* = 276.33         *F*(000) = 288
  Triclinic, *P*1         *D*~x~ = 1.442 Mg m^−3^
  *a* = 7.2341 (2) Å      Mo *K*α radiation, λ = 0.71073 Å
  *b* = 9.3852 (2) Å      Cell parameters from 2605 reflections
  *c* = 9.7971 (2) Å      θ = 2.1--26.4°
  α = 95.820 (1)°         µ = 0.26 mm^−1^
  β = 91.116 (1)°         *T* = 293 K
  γ = 105.682 (1)°        Block, yellow
  *V* = 636.33 (3) Å^3^   0.30 × 0.25 × 0.20 mm
  ----------------------- ---------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Data collection {#d1e280}
==========================================================================================

  ------------------------------------------------------------ --------------------------------------
  Bruker SMART APEXII area-detector diffractometer             2160 reflections with *I* \> 2σ(*I*)
  Radiation source: X-ray                                      *R*~int~ = 0.020
  ω and φ scans                                                θ~max~ = 26.4°, θ~min~ = 2.1°
  Absorption correction: multi-scan (*SADABS*; Bruker, 2008)   *h* = −9→9
  *T*~min~ = 0.742, *T*~max~ = 0.841                           *k* = −11→11
  9447 measured reflections                                    *l* = −10→12
  2605 independent reflections                                 
  ------------------------------------------------------------ --------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Refinement {#d1e396}
=====================================================================================

  ------------------------------------- -------------------------------------------------------------------------------------------------
  Refinement on *F*^2^                  Primary atom site location: structure-invariant direct methods
  Least-squares matrix: full            Secondary atom site location: difference Fourier map
  *R*\[*F*^2^ \> 2σ(*F*^2^)\] = 0.034   Hydrogen site location: mixed
  *wR*(*F*^2^) = 0.094                  H atoms treated by a mixture of independent and constrained refinement
  *S* = 1.05                            *w* = 1/\[σ^2^(*F*~o~^2^) + (0.0443*P*)^2^ + 0.1669*P*\] where *P* = (*F*~o~^2^ + 2*F*~c~^2^)/3
  2605 reflections                      (Δ/σ)~max~ \< 0.001
  192 parameters                        Δρ~max~ = 0.23 e Å^−3^
  0 restraints                          Δρ~min~ = −0.20 e Å^−3^
  ------------------------------------- -------------------------------------------------------------------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Special details {#d1e552}
==========================================================================================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å^2^) {#d1e571}
=============================================================================================================================================================================

  ----- -------------- --------------- -------------- -------------------- --
        *x*            *y*             *z*            *U*~iso~\*/*U*~eq~   
  S1    0.47564 (6)    0.24187 (5)     0.97878 (4)    0.04443 (15)         
  O1    0.1201 (2)     −0.07191 (14)   0.81504 (14)   0.0637 (4)           
  N1    0.4212 (3)     0.58093 (19)    0.63223 (17)   0.0509 (4)           
  H1A   0.470 (3)      0.652 (2)       0.584 (2)      0.059 (6)\*          
  H1B   0.299 (3)      0.546 (2)       0.641 (2)      0.066 (7)\*          
  N2    1.0373 (2)     0.60541 (19)    0.83751 (19)   0.0500 (4)           
  H2A   1.087 (3)      0.696 (2)       0.820 (2)      0.059 (6)\*          
  H2B   1.092 (3)      0.590 (2)       0.914 (2)      0.071 (7)\*          
  N3    0.45530 (19)   0.42030 (14)    0.78589 (14)   0.0378 (3)           
  N4    0.75997 (18)   0.44133 (14)    0.89781 (13)   0.0374 (3)           
  N5    0.2555 (2)     0.10689 (16)    0.67916 (14)   0.0395 (3)           
  H5    0.304 (3)      0.201 (2)       0.6830 (18)    0.046 (5)\*          
  N6    0.3287 (2)     0.11118 (16)    0.45436 (15)   0.0458 (4)           
  C1    0.5404 (2)     0.53494 (17)    0.71413 (16)   0.0373 (4)           
  C2    0.7366 (2)     0.59919 (18)    0.72509 (17)   0.0398 (4)           
  H2    0.795008       0.672763        0.670694       0.048\*              
  C3    0.8435 (2)     0.55043 (16)    0.81970 (16)   0.0367 (4)           
  C4    0.5717 (2)     0.38421 (16)    0.87394 (15)   0.0351 (4)           
  C5    0.2265 (2)     0.17793 (19)    0.91965 (17)   0.0452 (4)           
  H5A   0.149123       0.139634        0.994486       0.054\*              
  H5B   0.185101       0.261192        0.891905       0.054\*              
  C6    0.1943 (2)     0.05740 (18)    0.80001 (18)   0.0415 (4)           
  C7    0.2500 (2)     0.02603 (17)    0.55029 (17)   0.0369 (4)           
  C8    0.1697 (3)     −0.12615 (19)   0.5237 (2)     0.0506 (4)           
  H8    0.118824       −0.182978       0.593511       0.061\*              
  C9    0.1674 (3)     −0.1909 (2)     0.3911 (2)     0.0603 (5)           
  H9    0.113148       −0.292746       0.369861       0.072\*              
  C10   0.2447 (3)     −0.1056 (2)     0.2905 (2)     0.0574 (5)           
  H10   0.243138       −0.147400       0.200125       0.069\*              
  C11   0.3246 (3)     0.0435 (2)      0.32694 (19)   0.0551 (5)           
  H11   0.379420       0.101358        0.258857       0.066\*              
  ----- -------------- --------------- -------------- -------------------- --

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Atomic displacement parameters (Å^2^) {#d1e995}
================================================================================================================

  ----- ------------- ------------- ------------- --------------- -------------- --------------
        *U*^11^       *U*^22^       *U*^33^       *U*^12^         *U*^13^        *U*^23^
  S1    0.0510 (3)    0.0393 (2)    0.0344 (2)    −0.00414 (19)   0.00358 (18)   0.00918 (17)
  O1    0.0848 (10)   0.0348 (7)    0.0585 (8)    −0.0084 (6)     0.0102 (7)     0.0109 (6)
  N1    0.0466 (10)   0.0522 (10)   0.0532 (10)   0.0079 (8)      −0.0012 (8)    0.0183 (8)
  N2    0.0377 (8)    0.0444 (9)    0.0648 (11)   0.0003 (7)      0.0006 (7)     0.0222 (8)
  N3    0.0399 (7)    0.0308 (7)    0.0382 (7)    0.0019 (6)      0.0022 (6)     0.0041 (5)
  N4    0.0404 (8)    0.0310 (7)    0.0369 (7)    0.0020 (6)      0.0018 (6)     0.0064 (5)
  N5    0.0438 (8)    0.0288 (7)    0.0397 (8)    −0.0008 (6)     0.0032 (6)     0.0044 (6)
  N6    0.0523 (9)    0.0425 (8)    0.0418 (8)    0.0106 (7)      0.0039 (7)     0.0070 (6)
  C1    0.0443 (9)    0.0331 (8)    0.0332 (8)    0.0084 (7)      0.0034 (7)     0.0030 (6)
  C2    0.0427 (9)    0.0349 (8)    0.0411 (9)    0.0058 (7)      0.0085 (7)     0.0127 (7)
  C3    0.0395 (9)    0.0281 (8)    0.0397 (9)    0.0042 (6)      0.0063 (7)     0.0040 (6)
  C4    0.0427 (9)    0.0266 (7)    0.0311 (8)    0.0022 (6)      0.0056 (7)     −0.0004 (6)
  C5    0.0451 (10)   0.0417 (9)    0.0412 (9)    −0.0018 (7)     0.0134 (8)     0.0050 (7)
  C6    0.0385 (9)    0.0354 (9)    0.0458 (10)   0.0003 (7)      0.0037 (7)     0.0087 (7)
  C7    0.0319 (8)    0.0358 (8)    0.0419 (9)    0.0079 (6)      −0.0010 (7)    0.0038 (7)
  C8    0.0531 (11)   0.0375 (9)    0.0546 (11)   0.0026 (8)      0.0031 (9)     0.0009 (8)
  C9    0.0629 (13)   0.0441 (11)   0.0672 (13)   0.0099 (9)      −0.0011 (10)   −0.0111 (9)
  C10   0.0611 (12)   0.0643 (13)   0.0488 (11)   0.0266 (10)     −0.0007 (9)    −0.0100 (10)
  C11   0.0636 (12)   0.0607 (12)   0.0436 (10)   0.0204 (10)     0.0081 (9)     0.0073 (9)
  ----- ------------- ------------- ------------- --------------- -------------- --------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Geometric parameters (Å, º) {#d1e1349}
======================================================================================================

  ------------------- -------------- --------------------- --------------
  S1---C4             1.7682 (15)    N6---C7               1.332 (2)
  S1---C5             1.8021 (18)    N6---C11              1.338 (2)
  O1---C6             1.2124 (19)    C1---C2               1.381 (2)
  N1---C1             1.348 (2)      C2---C3               1.384 (2)
  N1---H1A            0.86 (2)       C2---H2               0.9300
  N1---H1B            0.86 (2)       C5---C6               1.512 (2)
  N2---C3             1.358 (2)      C5---H5A              0.9700
  N2---H2A            0.86 (2)       C5---H5B              0.9700
  N2---H2B            0.88 (2)       C7---C8               1.384 (2)
  N3---C4             1.324 (2)      C8---C9               1.376 (3)
  N3---C1             1.358 (2)      C8---H8               0.9300
  N4---C4             1.328 (2)      C9---C10              1.365 (3)
  N4---C3             1.3570 (19)    C9---H9               0.9300
  N5---C6             1.354 (2)      C10---C11             1.368 (3)
  N5---C7             1.400 (2)      C10---H10             0.9300
  N5---H5             0.856 (19)     C11---H11             0.9300
                                                           
  C4---S1---C5        102.83 (8)     C6---C5---S1          111.72 (12)
  C1---N1---H1A       118.3 (14)     C6---C5---H5A         109.3
  C1---N1---H1B       117.3 (15)     S1---C5---H5A         109.3
  H1A---N1---H1B      124 (2)        C6---C5---H5B         109.3
  C3---N2---H2A       117.2 (13)     S1---C5---H5B         109.3
  C3---N2---H2B       117.6 (15)     H5A---C5---H5B        107.9
  H2A---N2---H2B      110 (2)        O1---C6---N5          124.47 (16)
  C4---N3---C1        114.94 (13)    O1---C6---C5          121.07 (15)
  C4---N4---C3        115.04 (13)    N5---C6---C5          114.46 (14)
  C6---N5---C7        129.23 (14)    N6---C7---C8          123.05 (16)
  C6---N5---H5        114.6 (12)     N6---C7---N5          112.92 (13)
  C7---N5---H5        116.2 (12)     C8---C7---N5          124.02 (15)
  C7---N6---C11       116.91 (15)    C9---C8---C7          118.03 (18)
  N1---C1---N3        115.65 (15)    C9---C8---H8          121.0
  N1---C1---C2        122.72 (15)    C7---C8---H8          121.0
  N3---C1---C2        121.63 (15)    C10---C9---C8         120.00 (18)
  C1---C2---C3        117.79 (14)    C10---C9---H9         120.0
  C1---C2---H2        121.1          C8---C9---H9          120.0
  C3---C2---H2        121.1          C9---C10---C11        117.86 (18)
  N4---C3---N2        116.08 (15)    C9---C10---H10        121.1
  N4---C3---C2        121.51 (14)    C11---C10---H10       121.1
  N2---C3---C2        122.39 (15)    N6---C11---C10        124.13 (18)
  N3---C4---N4        128.88 (14)    N6---C11---H11        117.9
  N3---C4---S1        119.16 (12)    C10---C11---H11       117.9
  N4---C4---S1        111.95 (12)                          
                                                           
  C4---N3---C1---N1   −174.86 (14)   C7---N5---C6---O1     −0.5 (3)
  C4---N3---C1---C2   5.2 (2)        C7---N5---C6---C5     179.12 (15)
  N1---C1---C2---C3   175.39 (15)    S1---C5---C6---O1     105.06 (17)
  N3---C1---C2---C3   −4.7 (2)       S1---C5---C6---N5     −74.58 (17)
  C4---N4---C3---N2   −176.87 (14)   C11---N6---C7---C8    1.2 (2)
  C4---N4---C3---C2   1.5 (2)        C11---N6---C7---N5    −178.11 (15)
  C1---C2---C3---N4   1.2 (2)        C6---N5---C7---N6     −178.11 (16)
  C1---C2---C3---N2   179.38 (15)    C6---N5---C7---C8     2.5 (3)
  C1---N3---C4---N4   −2.5 (2)       N6---C7---C8---C9     −1.7 (3)
  C1---N3---C4---S1   177.30 (10)    N5---C7---C8---C9     177.57 (17)
  C3---N4---C4---N3   −0.8 (2)       C7---C8---C9---C10    0.7 (3)
  C3---N4---C4---S1   179.39 (10)    C8---C9---C10---C11   0.7 (3)
  C5---S1---C4---N3   3.32 (14)      C7---N6---C11---C10   0.2 (3)
  C5---S1---C4---N4   −176.85 (11)   C9---C10---C11---N6   −1.2 (3)
  C4---S1---C5---C6   87.65 (13)                           
  ------------------- -------------- --------------------- --------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyridin-2-yl)acetamide (I). Hydrogen-bond geometry (Å, º) {#d1e1905}
========================================================================================================

  ---------------------- ---------- ---------- ----------- ---------------
  *D*---H···*A*          *D*---H    H···*A*    *D*···*A*   *D*---H···*A*
  N5---H5···N3           0.86 (2)   2.18 (2)   2.975 (2)   154 (2)
  C8---H8···O1           0.93       2.31       2.894 (2)   121
  N2---H2*B*···N4^i^     0.88 (2)   2.20 (2)   3.082 (2)   178 (2)
  N1---H1*A*···N6^ii^    0.86 (2)   2.38 (2)   3.174 (2)   155 (2)
  N2---H2*A*···O1^iii^   0.86 (2)   2.13 (2)   2.956 (2)   159 (2)
  ---------------------- ---------- ---------- ----------- ---------------

Symmetry codes: (i) −*x*+2, −*y*+1, −*z*+2; (ii) −*x*+1, −*y*+1, −*z*+1; (iii) *x*+1, *y*+1, *z*.

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Crystal data {#d1e2080}
========================================================================================

  ------------------------- ---------------------------------------
  C~10~H~11~N~7~OS          *F*(000) = 576
  *M~r~* = 277.32           *D*~x~ = 1.453 Mg m^−3^
  Monoclinic, *P*2~1~/*n*   Mo *K*α radiation, λ = 0.71073 Å
  *a* = 12.1333 (5) Å       Cell parameters from 3124 reflections
  *b* = 8.1561 (3) Å        θ = 2.2--28.3°
  *c* = 12.8442 (5) Å       µ = 0.26 mm^−1^
  β = 94.307 (3)°           *T* = 293 K
  *V* = 1267.48 (9) Å^3^    Block, yellow
  *Z* = 4                   0.28 × 0.25 × 0.20 mm
  ------------------------- ---------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Data collection {#d1e2204}
===========================================================================================

  ------------------------------------------------------------ --------------------------------------
  Bruker SMART APEXII area-detector diffractometer             1320 reflections with *I* \> 2σ(*I*)
  Radiation source: X-ray                                      *R*~int~ = 0.084
  ω and φ scans                                                θ~max~ = 28.3°, θ~min~ = 2.2°
  Absorption correction: multi-scan (*SADABS*; Bruker, 2008)   *h* = −16→12
  *T*~min~ = 0.723, *T*~max~ = 0.863                           *k* = −10→9
  11968 measured reflections                                   *l* = −17→17
  3124 independent reflections                                 
  ------------------------------------------------------------ --------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Refinement {#d1e2320}
======================================================================================

  ------------------------------------- -------------------------------------------------------------------------------------
  Refinement on *F*^2^                  Primary atom site location: structure-invariant direct methods
  Least-squares matrix: full            Secondary atom site location: difference Fourier map
  *R*\[*F*^2^ \> 2σ(*F*^2^)\] = 0.054   Hydrogen site location: mixed
  *wR*(*F*^2^) = 0.126                  H atoms treated by a mixture of independent and constrained refinement
  *S* = 0.94                            *w* = 1/\[σ^2^(*F*~o~^2^) + (0.0452*P*)^2^\] where *P* = (*F*~o~^2^ + 2*F*~c~^2^)/3
  3124 reflections                      (Δ/σ)~max~ = 0.001
  192 parameters                        Δρ~max~ = 0.20 e Å^−3^
  0 restraints                          Δρ~min~ = −0.23 e Å^−3^
  ------------------------------------- -------------------------------------------------------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Special details {#d1e2473}
===========================================================================================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å^2^) {#d1e2492}
==============================================================================================================================================================================

  ----- -------------- -------------- -------------- -------------------- --
        *x*            *y*            *z*            *U*~iso~\*/*U*~eq~   
  S1    0.77107 (6)    0.20394 (11)   0.50448 (6)    0.0525 (3)           
  O1    1.06221 (18)   0.2503 (3)     0.55054 (17)   0.0779 (8)           
  N1    0.6951 (3)     0.2961 (4)     0.8740 (2)     0.0651 (9)           
  H1A   0.651 (3)      0.297 (4)      0.923 (3)      0.084 (13)\*         
  H1B   0.760 (3)      0.342 (4)      0.881 (3)      0.079 (13)\*         
  N2    0.4369 (2)     0.0046 (4)     0.6423 (3)     0.0635 (9)           
  H2A   0.391 (2)      −0.015 (4)     0.687 (2)      0.060 (11)\*         
  H2B   0.423 (2)      −0.044 (4)     0.571 (3)      0.080 (11)\*         
  N3    0.72886 (19)   0.2473 (3)     0.70403 (17)   0.0452 (7)           
  N4    0.59901 (19)   0.1011 (3)     0.58901 (17)   0.0463 (7)           
  N5    0.9712 (2)     0.1889 (3)     0.69294 (19)   0.0494 (7)           
  H5    0.912 (2)      0.197 (4)      0.719 (2)      0.057 (11)\*         
  N6    1.0164 (2)     0.0445 (3)     0.84291 (19)   0.0545 (7)           
  N7    1.2266 (2)     −0.0273 (4)    0.7815 (2)     0.0659 (8)           
  C1    0.6580 (3)     0.2321 (4)     0.7813 (2)     0.0450 (8)           
  C2    0.5579 (2)     0.1540 (4)     0.7649 (2)     0.0466 (8)           
  H2    0.509877       0.146453       0.817830       0.056\*              
  C3    0.5306 (2)     0.0872 (4)     0.6680 (2)     0.0438 (8)           
  C4    0.6909 (2)     0.1845 (4)     0.6132 (2)     0.0421 (7)           
  C5    0.8779 (2)     0.3427 (4)     0.5525 (2)     0.0497 (9)           
  H5A   0.897729       0.412594       0.495784       0.060\*              
  H5B   0.849528       0.412281       0.605640       0.060\*              
  C6    0.9796 (3)     0.2561 (4)     0.5981 (2)     0.0499 (9)           
  C7    1.0498 (2)     0.0968 (4)     0.7528 (2)     0.0440 (8)           
  C8    1.1544 (3)     0.0605 (4)     0.7222 (3)     0.0613 (10)          
  H8    1.174535       0.098921       0.658172       0.074\*              
  C9    1.1922 (3)     −0.0808 (4)    0.8710 (3)     0.0610 (10)          
  H9    1.239366       −0.144894      0.914481       0.073\*              
  C10   1.0895 (3)     −0.0446 (4)    0.9011 (2)     0.0598 (9)           
  H10   1.069630       −0.083866      0.965011       0.072\*              
  ----- -------------- -------------- -------------- -------------------- --

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Atomic displacement parameters (Å^2^) {#d1e2904}
=================================================================================================================

  ----- ------------- ------------- ------------- -------------- ------------- --------------
        *U*^11^       *U*^22^       *U*^33^       *U*^12^        *U*^13^       *U*^23^
  S1    0.0478 (5)    0.0731 (6)    0.0376 (4)    −0.0116 (5)    0.0092 (3)    −0.0006 (4)
  O1    0.0459 (15)   0.134 (3)     0.0572 (14)   0.0005 (14)    0.0236 (12)   0.0208 (14)
  N1    0.062 (2)     0.091 (2)     0.0445 (17)   −0.021 (2)     0.0163 (16)   −0.0161 (17)
  N2    0.0446 (19)   0.090 (3)     0.0569 (19)   −0.0240 (17)   0.0124 (16)   −0.0020 (18)
  N3    0.0437 (16)   0.0552 (19)   0.0379 (13)   −0.0049 (12)   0.0104 (12)   −0.0024 (12)
  N4    0.0372 (15)   0.0617 (18)   0.0408 (14)   −0.0088 (14)   0.0095 (12)   −0.0002 (13)
  N5    0.0379 (18)   0.069 (2)     0.0428 (15)   −0.0018 (16)   0.0162 (13)   0.0043 (14)
  N6    0.0478 (17)   0.072 (2)     0.0447 (15)   0.0030 (15)    0.0119 (13)   0.0055 (14)
  N7    0.0512 (19)   0.079 (2)     0.0690 (19)   0.0126 (17)    0.0169 (15)   0.0064 (17)
  C1    0.049 (2)     0.046 (2)     0.0402 (16)   0.0041 (16)    0.0087 (15)   −0.0021 (15)
  C2    0.042 (2)     0.058 (2)     0.0416 (17)   −0.0005 (17)   0.0110 (14)   0.0027 (15)
  C3    0.0338 (19)   0.049 (2)     0.0493 (18)   0.0015 (16)    0.0076 (15)   0.0061 (16)
  C4    0.0395 (19)   0.047 (2)     0.0410 (16)   0.0036 (16)    0.0083 (14)   0.0024 (15)
  C5    0.047 (2)     0.055 (2)     0.0479 (18)   −0.0136 (16)   0.0103 (15)   0.0067 (15)
  C6    0.044 (2)     0.061 (2)     0.0449 (18)   −0.0142 (17)   0.0067 (16)   0.0004 (16)
  C7    0.0338 (19)   0.053 (2)     0.0463 (18)   −0.0016 (16)   0.0105 (15)   −0.0048 (16)
  C8    0.053 (2)     0.076 (3)     0.057 (2)     0.007 (2)      0.0187 (18)   0.0088 (19)
  C9    0.054 (2)     0.073 (3)     0.057 (2)     0.012 (2)      0.0051 (17)   0.0020 (19)
  C10   0.061 (3)     0.069 (3)     0.0508 (19)   0.002 (2)      0.0107 (18)   0.0063 (19)
  ----- ------------- ------------- ------------- -------------- ------------- --------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Geometric parameters (Å, º) {#d1e3270}
=======================================================================================================

  ------------------- ------------- -------------------- ------------
  S1---C4             1.768 (3)     N6---C7              1.325 (3)
  S1---C5             1.795 (3)     N6---C10             1.331 (4)
  O1---C6             1.213 (3)     N7---C8              1.326 (4)
  N1---C1             1.346 (4)     N7---C9              1.326 (4)
  N1---H1A            0.86 (3)      C1---C2              1.374 (4)
  N1---H1B            0.88 (3)      C2---C3              1.375 (4)
  N2---C3             1.341 (4)     C2---H2              0.9300
  N2---H2A            0.85 (3)      C5---C6              1.502 (4)
  N2---H2B            1.00 (3)      C5---H5A             0.9700
  N3---C4             1.325 (3)     C5---H5B             0.9700
  N3---C1             1.367 (3)     C7---C8              1.389 (4)
  N4---C4             1.323 (3)     C8---H8              0.9300
  N4---C3             1.364 (3)     C9---C10             1.364 (4)
  N5---C6             1.347 (4)     C9---H9              0.9300
  N5---C7             1.398 (4)     C10---H10            0.9300
  N5---H5             0.82 (3)                           
                                                         
  C4---S1---C5        102.17 (14)   N4---C4---S1         111.4 (2)
  C1---N1---H1A       118 (2)       N3---C4---S1         119.0 (2)
  C1---N1---H1B       120 (2)       C6---C5---S1         112.8 (2)
  H1A---N1---H1B      122 (3)       C6---C5---H5A        109.0
  C3---N2---H2A       121 (2)       S1---C5---H5A        109.0
  C3---N2---H2B       120.4 (17)    C6---C5---H5B        109.0
  H2A---N2---H2B      118 (3)       S1---C5---H5B        109.0
  C4---N3---C1        114.1 (2)     H5A---C5---H5B       107.8
  C4---N4---C3        114.7 (3)     O1---C6---N5         124.1 (3)
  C6---N5---C7        128.4 (3)     O1---C6---C5         120.5 (3)
  C6---N5---H5        118 (2)       N5---C6---C5         115.4 (3)
  C7---N5---H5        114 (2)       N6---C7---C8         121.7 (3)
  C7---N6---C10       115.5 (3)     N6---C7---N5         114.4 (3)
  C8---N7---C9        116.0 (3)     C8---C7---N5         124.0 (3)
  N1---C1---N3        114.9 (3)     N7---C8---C7         122.1 (3)
  N1---C1---C2        123.3 (3)     N7---C8---H8         119.0
  N3---C1---C2        121.9 (3)     C7---C8---H8         119.0
  C1---C2---C3        118.2 (3)     N7---C9---C10        121.9 (3)
  C1---C2---H2        120.9         N7---C9---H9         119.1
  C3---C2---H2        120.9         C10---C9---H9        119.1
  N2---C3---N4        114.2 (3)     N6---C10---C9        122.9 (3)
  N2---C3---C2        124.3 (3)     N6---C10---H10       118.5
  N4---C3---C2        121.4 (3)     C9---C10---H10       118.5
  N4---C4---N3        129.6 (3)                          
                                                         
  C4---N3---C1---N1   −179.7 (3)    C7---N5---C6---O1    −2.8 (5)
  C4---N3---C1---C2   1.7 (4)       C7---N5---C6---C5    177.6 (3)
  N1---C1---C2---C3   −177.3 (3)    S1---C5---C6---O1    105.2 (3)
  N3---C1---C2---C3   1.3 (5)       S1---C5---C6---N5    −75.2 (3)
  C4---N4---C3---N2   179.0 (3)     C10---N6---C7---C8   −0.1 (5)
  C4---N4---C3---C2   −0.9 (4)      C10---N6---C7---N5   179.5 (3)
  C1---C2---C3---N2   178.4 (3)     C6---N5---C7---N6    −178.8 (3)
  C1---C2---C3---N4   −1.7 (5)      C6---N5---C7---C8    0.8 (5)
  C3---N4---C4---N3   4.6 (5)       C9---N7---C8---C7    1.1 (5)
  C3---N4---C4---S1   −177.3 (2)    N6---C7---C8---N7    −0.4 (5)
  C1---N3---C4---N4   −5.0 (5)      N5---C7---C8---N7    180.0 (3)
  C1---N3---C4---S1   177.1 (2)     C8---N7---C9---C10   −1.3 (5)
  C5---S1---C4---N4   172.4 (2)     C7---N6---C10---C9   −0.1 (5)
  C5---S1---C4---N3   −9.3 (3)      N7---C9---C10---N6   0.9 (5)
  C4---S1---C5---C6   93.4 (2)                           
  ------------------- ------------- -------------------- ------------

2-\[(4,6-Diaminopyrimidin-2-yl)sulfanyl\]-*N*-(pyrazin-2-yl)acetamide (II). Hydrogen-bond geometry (Å, º) {#d1e3819}
=========================================================================================================

  ---------------------- ---------- ---------- ----------- ---------------
  *D*---H···*A*          *D*---H    H···*A*    *D*···*A*   *D*---H···*A*
  N5---H5···N3           0.82 (3)   2.25 (3)   2.993 (4)   151 (3)
  C8---H8···O1           0.93       2.24       2.854 (4)   123
  N2---H2*B*···N4^i^     1.00 (3)   2.11 (3)   3.092 (4)   169 (3)
  N1---H1*A*···O1^ii^    0.86 (3)   2.06 (4)   2.904 (4)   167 (3)
  N2---H2*A*···N7^iii^   0.85 (3)   2.41 (3)   3.235 (4)   164 (3)
  C9---H9···O1^iv^       0.93       2.56       3.368 (4)   145
  ---------------------- ---------- ---------- ----------- ---------------

Symmetry codes: (i) −*x*+1, −*y*, −*z*+1; (ii) *x*−1/2, −*y*+1/2, *z*+1/2; (iii) *x*−1, *y*, *z*; (iv) −*x*+5/2, *y*−1/2, −*z*+3/2.

![The mol­ecular structure of the compound (I)[](#scheme1){ref-type="chem"}, showing the atom labelling and displacement ellipsoids drawn at the 50% probability level. The intra­molecular N---H⋯N and C---H⋯O hydrogen bonds (see Table 1[▸](#table1){ref-type="table"}) are shown as dashed lines.](e-74-00718-fig1){#fig1}

![The mol­ecular structure of the compound (II)[](#scheme1){ref-type="chem"}, showing the atom labelling and displacement ellipsoids drawn at the 50% probability level. The intra­molecular N---H⋯N and C---H⋯O hydrogen bonds (see Table 2[▸](#table2){ref-type="table"}) are shown as dashed lines.](e-74-00718-fig2){#fig2}

![A view normal to the (1 ) plane of the crystal packing of compound (I)[](#scheme1){ref-type="chem"}. The hydrogen bonds (see Table 1[▸](#table1){ref-type="table"}) are shown as dashed lines and C-bound H atoms have been omitted for clarity.](e-74-00718-fig3){#fig3}

![A view along the *a* axis of the crystal packing of compound (II)[](#scheme1){ref-type="chem"}. The hydrogen bonds (see Table 2[▸](#table2){ref-type="table"}) are shown as dashed lines, and C-bound H atoms have been omitted for clarity.](e-74-00718-fig4){#fig4}

![Ball and stick, Hirshfeld surface and electrostatic potential surface diagrams for compound (I)[](#scheme1){ref-type="chem"}.](e-74-00718-fig5){#fig5}

![Ball and stick, Hirshfeld surface and electrostatic potential surface diagrams for compound (II)[](#scheme1){ref-type="chem"}.](e-74-00718-fig6){#fig6}

![The 2D fingerprint plot for all the inter­molecular contacts for compound (I)[](#scheme1){ref-type="chem"}.](e-74-00718-fig7){#fig7}

![The 2D fingerprint plot for all the inter­molecular contacts for compound (II)[](#scheme1){ref-type="chem"}.](e-74-00718-fig8){#fig8}

###### Hydrogen-bond geometry (Å, °) for (I)[](#scheme1){ref-type="chem"}

  *D*---H⋯*A*          *D*---H    H⋯*A*      *D*⋯*A*     *D*---H⋯*A*
  -------------------- ---------- ---------- ----------- -------------
  N5---H5⋯N3           0.86 (2)   2.18 (2)   2.975 (2)   154 (2)
  C8---H8⋯O1           0.93       2.31       2.894 (2)   121
  N2---H2*B*⋯N4^i^     0.88 (2)   2.20 (2)   3.082 (2)   178 (2)
  N1---H1*A*⋯N6^ii^    0.86 (2)   2.38 (2)   3.174 (2)   155 (2)
  N2---H2*A*⋯O1^iii^   0.86 (2)   2.13 (2)   2.956 (2)   159 (2)

Symmetry codes: (i) ; (ii) ; (iii) .

###### Hydrogen-bond geometry (Å, °) for (II)[](#scheme1){ref-type="chem"}

  *D*---H⋯*A*          *D*---H    H⋯*A*      *D*⋯*A*     *D*---H⋯*A*
  -------------------- ---------- ---------- ----------- -------------
  N5---H5⋯N3           0.82 (3)   2.25 (3)   2.993 (4)   151 (3)
  C8---H8⋯O1           0.93       2.24       2.854 (4)   123
  N2---H2*B*⋯N4^i^     1.00 (3)   2.11 (3)   3.092 (4)   169 (3)
  N1---H1*A*⋯O1^ii^    0.86 (3)   2.06 (4)   2.904 (4)   167 (3)
  N2---H2*A*⋯N7^iii^   0.85 (3)   2.41 (3)   3.235 (4)   164 (3)
  C9---H9⋯O1^iv^       0.93       2.56       3.368 (4)   145

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

###### Experimental details

                                                                             \(I\)                                                                    \(II\)
  -------------------------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------------------------------------
  Crystal data                                                                                                                                        
  Chemical formula                                                           C~11~H~12~N~6~OS                                                         C~10~H~11~N~7~OS
  *M* ~r~                                                                    276.33                                                                   277.32
  Crystal system, space group                                                Triclinic, *P*                                                           Monoclinic, *P*2~1~/*n*
  Temperature (K)                                                            293                                                                      293
  *a*, *b*, *c* (Å)                                                          7.2341 (2), 9.3852 (2), 9.7971 (2)                                       12.1333 (5), 8.1561 (3), 12.8442 (5)
  α, β, γ (°)                                                                95.820 (1), 91.116 (1), 105.682 (1)                                      90, 94.307 (3), 90
  *V* (Å^3^)                                                                 636.33 (3)                                                               1267.48 (9)
  *Z*                                                                        2                                                                        4
  Radiation type                                                             Mo *K*α                                                                  Mo *K*α
  μ (mm^−1^)                                                                 0.26                                                                     0.26
  Crystal size (mm)                                                          0.30 × 0.25 × 0.20                                                       0.28 × 0.25 × 0.20
                                                                                                                                                      
  Data collection                                                                                                                                     
  Diffractometer                                                             Bruker SMART APEXII area-detector                                        Bruker SMART APEXII area-detector
  Absorption correction                                                      Multi-scan (*SADABS*; Bruker, 2008[@bb1])                                Multi-scan (*SADABS*; Bruker, 2008[@bb1])
  *T* ~min~, *T* ~max~                                                       0.742, 0.841                                                             0.723, 0.863
  No. of measured, independent and observed \[*I* \> 2σ(*I*)\] reflections   9447, 2605, 2160                                                         11968, 3124, 1320
  *R* ~int~                                                                  0.020                                                                    0.084
  (sin θ/λ)~max~ (Å^−1^)                                                     0.626                                                                    0.667
                                                                                                                                                      
  Refinement                                                                                                                                          
  *R*\[*F* ^2^ \> 2σ(*F* ^2^)\], *wR*(*F* ^2^), *S*                          0.034, 0.094, 1.05                                                       0.054, 0.126, 0.94
  No. of reflections                                                         2605                                                                     3124
  No. of parameters                                                          192                                                                      192
  H-atom treatment                                                           H atoms treated by a mixture of independent and constrained refinement   H atoms treated by a mixture of independent and constrained refinement
  Δρ~max~, Δρ~min~ (e Å^−3^)                                                 0.23, −0.20                                                              0.20, −0.23

Computer programs: *APEX2* and *SAINT* (Bruker, 2008[@bb1]), *SHELXS97* (Sheldrick, 2008[@bb12]), *SHELXL2016* (Sheldrick, 2015[@bb13]), *PLATON* (Spek, 2009[@bb14]) and *Mercury* (Macrae *et al.*, 2008[@bb8]).
